ClinicalTrials.Veeva

Menu
Q

Queen Anne Street Medical Centre | London, UK

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Astegolimab
Brenipatide
GDC-6599
LY3537031
RO7790121
UPB-101

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 8 total trials

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) (RENEW-COPD)

The main purpose of this study is to assess if different dose levels of Brenipatide are safe and work the way they are intended to work in participan...

Not yet enrolling
Pulmonary Disease, Chronic Obstructive
Drug: Placebo
Drug: Brenipatide
Locations recently updated

This Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety of induction and maintenance...

Enrolling
Moderately to Severely Active Crohns Disease
Drug: Placebo
Drug: Afimkibart

A Randomized, Double-blind, Placebo-controlled, Multiple Dose-Ranging Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic...

Active, not recruiting
COPD
Other: Placebo
Biological: Biological: Solrikitug high dose

The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmo...

Active, not recruiting
Chronic Obstructive Pulmonary Disease
Drug: Astegolimab

Trial sponsors

Genentech logo
Roche logo
Lilly logo
T
U
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems